The author examines the productivity of the Department of Defense's biodefense research program over the course of more than 35 years, coupled with changes in the global research environment since the events of September 11, 2001. Where the deployment of a biologic agent of mass destruction is largely an unpredictable risk, the outcome certainly could be catastrophic for an unprotected population. An urgent moral imperative is cast upon the federal government, then, to objectively assess the application and management of ...
Read More
The author examines the productivity of the Department of Defense's biodefense research program over the course of more than 35 years, coupled with changes in the global research environment since the events of September 11, 2001. Where the deployment of a biologic agent of mass destruction is largely an unpredictable risk, the outcome certainly could be catastrophic for an unprotected population. An urgent moral imperative is cast upon the federal government, then, to objectively assess the application and management of its biodefense research resources.
Read Less
Publisher:
Strategic Studies Institute U. S. Army War College
Published:
2007
Language:
English
Alibris ID:
16981460111
Shipping Options:
Standard Shipping: $4.66
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Good. Good condition. Paperback edition. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains.
Publisher:
Strategic Studies Institute U. S. Army War College
Published:
2007
Language:
English
Alibris ID:
13469939828
Shipping Options:
Standard Shipping: $4.66
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. No dust jacket. Cover has slight wear and soiling. v, [1], 38 p. Illustrations. Endnotes. From an on-line posting: "The author examines why, despite devoting decades of research to developing countermeasures against biological agents, the Department of Defense has few products in its arsenal. She concludes that the military requires significant change in program structure and management to begin fielding protective drugs and vaccines for the warfighter efficiently. Colonel Coleen K. Martinez is currently assigned as the Director of Medical Systems for the U.S. Army Medical Research and Materiel Command with duty at the Office of the Assistant Secretary of the Army for Acquisition, Logistics, and Technology in the Pentagon. She has deployed in support of medical operations in Bosnia, Kuwait, and Iraq. She is a graduate of the U.S. Army's Command and General Staff College and the U.S. Army War College, and holds a Ph.D. in Immunology from Virginia Commonwealth University. The above information may not be current. It was current when the individual was published by SSI."
